Matthew B. Klein, CHIEF EXECUTIVE OFFICER at PTC THERAPEUTICS, INC. (PTCT), sold 7,371 shares at $69.36 ($511K) on 2026-02-18, disclosed to the SEC on 2026-02-20.
Open-market sale of $511k PTCT by CHIEF EXECUTIVE OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| PTCT | SELL | 2026-05-15 | $917K | — | Filing → |
| PTCT | SELL | 2026-04-23 | $202K | — | Filing → |
| PTCT | SELL | 2026-03-13 | $171K | — | Filing → |